Pharmaceutical Compositions of Cabozantinib
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- SLAYBACK PHARMA LLC, Princeton, New Jersey has been assigned a patent (No. US 12138255 B2, initially filed May 5, 2023) developed by five inventors Sushant Omprakash Dube, Maharashtra, India; Suprit Dilip Saoji, Maharashtra, India; Pankaj Kisan Chatki, Telangana, India; Sumitra Ashokkumar Pillai, Telangana, India; and Girish G. Kore, Maharashtra, India, for "Pharmaceutical compositions of cabozantinib." . . .